Association of OAS1 gene polymorphism with the severity of COVID‑19 infection
Authors:
Open Access
- 9 October 2024
- journal article
- Published by Spandidos Publications in World Academy of Sciences Journal
- Vol. 6 (6) , 1-9
Abstract
The ongoing coronavirus disease 2019 (COVID‑19) pandemic has underscored the critical need to investigate host genetic factors that may influence disease susceptibility and severity. Among these, the 2'‑5'‑oligoadenylate synthase 1 (OAS1) single nucleotide polymorphism (SNP) rs10774671 has been implicated in the antiviral response against coronaviruses and clinical outcomes. The aim of the present retrospective study was to investigate the association between the OAS1 gene polymorphism and the severity of COVID‑19. A total of 200 subjects were enrolled, including 75 healthy controls and 125 patients with COVID‑19. The OAS1 SNP rs10774671 was assessed using PCR‑RFLP analysis. The findings revealed an upward trend in the prevalence of the A allele among individuals, who developed a severe course of COVID‑19. Specifically, 17.8% of the patients with severe infection carried the GG genotype, 52.8% had the GA genotype and 30.4% carried the AA genotype (P=0.0001). Notably, the AA genotype was exclusively detected in patients with severe COVID‑19 infection (P<0.0001). Moreover, the frequency of the A allele was markedly higher than that of the G allele in patients with severe COVID‑19 infection (P=0.0001). Multivariate analysis revealed that individuals with the rs10774671 AA genotype had a 6.8‑fold greater likelihood of progressing to a more severe course of COVID‑19 (odds ratio, 6.86; 95% CI, 2.83‑16.63; P<0.0001). Thus, the OAS1 SNP rs10774671 holds promise as a potential genetic marker that could be valuable in predicting the progression and outcome of COVID‑19 infection.Keywords
This publication has 49 references indexed in Scilit:
- Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connectionArchives of Virology, 2024
- SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissuesCell Reports, 2021
- Actual Racial/Ethnic Disparities in COVID-19 Mortality for the Non-Hispanic Black Compared to Non-Hispanic White Population in 353 US Counties and Their Association with Structural RacismJournal of Racial and Ethnic Health Disparities, 2021
- The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19Cytokine, 2021
- Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 casesHeliyon, 2020
- ACE2, TMPRSS2, and Furin variants and SARS‐CoV‐2 infection in Madrid, SpainJournal of Medical Virology, 2020
- Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 PatientsCell Host & Microbe, 2020
- Structural variations in human ACE2 may influence its binding with SARS‐CoV‐2 spike proteinJournal of Medical Virology, 2020
- RNA regulation of the antiviral protein 2′‐5′‐oligoadenylate synthetaseWIREs RNA, 2019
- Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysisHuman Genetics, 2011